# Evonik and Phathom Pharmaceuticals sign supply agreement for vonoprazan

Evonik entered into a long-term supply agreement with Phathom Pharmaceuticals to produce commercial quantities of the drug substance vonoprazan at its sites in Tippecanoe, Indiana, USA and Dossenheim, Germany. The agreement was announced on October 10, 2022.

- Type: Contract
- Announced: 2022-10-10
- Where: Tippecanoe, Indiana and Dossenheim, Germany, United States
- Status: announced
- Products: vonoprazan (active pharmaceutical ingredient)
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Evonik Industries](https://endata.com/companies/5809.md) (supplier)
- [Phathom Pharmaceuticals](https://endata.com/companies/66230.md) (customer)

## Sources

- [prnewswire.co.uk](https://www.prnewswire.co.uk/news-releases/evonik-and-phathom-pharmaceuticals-partner-to-produce-novel-acid-blocker-vonoprazan-301643541.html), 2022-10-10: "Evonik has entered into a long-term supply agreement with Phathom Pharmaceuticals... to produce large-scale volumes of vonoprazan."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.